Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged Post author: Post published:May 3, 2024 Post category:uncategorized Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs). You Might Also Like Cocoa flavanols can protect the vascular system from stress November 18, 2024 SolasCure selected for innovate UK global incubator programme in houston June 3, 2024 Individuals with genetic predisposition for physical activity have fewer cardiovascular risk factors November 6, 2023
Individuals with genetic predisposition for physical activity have fewer cardiovascular risk factors November 6, 2023